Strong hospital sales push Zoll to double-digit gains for 2008

Zoll Medical, a manufacturer of resuscitation devices and software solutions, has reported an increase in revenues and net income for its 2008 fiscal year.

The company booked an increase of 29 percent to $398 million for 2008, compared to fiscal 2007 revenues of $309.4 million.

The Chelmsford, Mass.-based Zoll said that its net income for the year increased 41 percent to $23.4 million, compared to $16.66 million in the prior year. Backlog was approximately $7.9 million at the end of the fiscal year, according to the company.

Annual sales to the North American market increased by 27 percent to $301.4 million, compared to $237.4 million for the prior year. Sales to the North American hospital market increased 37 percent to $117.1 million, compared to $85.3 million last year. Excluding military sales, Zoll said its North American hospital sales increased 24 percent from $73.4 million to $90.9 million.

Around the web

RBMA President Peter Moffatt discusses declining reimbursement rates, recruiting challenges and the role of artificial intelligence in transforming the industry.

Deepak Bhatt, MD, director of the Mount Sinai Fuster Heart Hospital and principal investigator of the TRANSFORM trial, explains an emerging technique for cardiac screening: combining coronary CT angiography with artificial intelligence for plaque analysis to create an approach similar to mammography.

A total of 16 cardiology practices from 12 states settled with the DOJ to resolve allegations they overbilled Medicare for imaging agents used to diagnose cardiovascular disease.